Skip to content
cardio.webdr
ToolsSpecialtiesEchoHeart sounds
ToolsSpecialtiesEchoHeart soundsFavoritesPrivate notes
cardio.webdr

Clinical clarity, in seconds. Built for focused decisions—not data collection.

Patient inputs stay on this device.
ExploreAll toolsSpecialtiesEchocardiographyHeart sounds
Your workspaceFavoritesPrivate notesCalculation historyOffline access
PlatformAboutFAQDevelopersFeedbackContact
© 2026 CardioWebdr Clinical support, not a substitute for judgment.PrivacyTermsStorageSupportReport an issue
All tools/General Cardiovascular Risk Assessment Scores
Interactive worksheet9 clinical inputsPatient data not stored

ASCVD 10-Year Risk Estimator

About the : The ASCVD (Atherosclerotic Cardiovascular Disease) 10-Year Risk Estimator is a predictive tool developed by the American College of Cardiology (ACC) and the American Heart Association (AHA) to estimate the probability of a first cardiovascular event (myocardial infarction, stroke, or cardiovascular death) over the next 10 years. It is based on pooled cohort equations derived from large-scale U.S. populati

Interactive worksheet

Clinical inputs

0/9 filled
Inputs stay on this device
Active structured worksheetActive local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.
Clinical contextWhy this tool matters and how to interpret it

Understand the result,
not just the number.

About the ASCVD 10-Year Risk Estimator: The ASCVD (Atherosclerotic Cardiovascular Disease) 10-Year Risk Estimator is a predictive tool developed by the American College of Cardiology (ACC) and the American Heart Association (AHA) to estimate the probability of a first cardiovascular event (myocardial infarction, stroke, or cardiovascular death) over the next 10 years. It is based on pooled cohort equations derived from large-scale U.S. population studies, incorporating age, sex, race, cholesterol levels, blood pressure, diabetes, smoking status, and hypertension treatment as primary risk determinants. Clinical Interpretation: - < 5%: Low risk — emphasize lifestyle modification. - 5-7.4%: Borderline — consider risk enhancers before initiating therapy. - 7.5-19.9%: Intermediate — moderate-intensity statin is reasonable. - >20%: High — high-intensity statin recommended.

Clinical Significance: This calculator supports shared decision-making between clinician and patient to guide lipid-lowering therapy and preventive strategies.

Evidence & references1 primary source mapped
  1. Source 1

    Goff DC Jr, et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. J Am Coll Cardiol. 2014;63(25 Pt B):2935-2959. Grundy SM, et al. 2018 ACC/AHA Guideline on the Management of Blood Cholesterol. J Am Coll Cardiol. 2019;73(24):e285-e350. Arnett DK, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. J Am Coll Cardiol. 2019;74(10):e177-e232.

Clinical discussionModerated, tool-specific conversation

Loading discussion…

Moderated before publishingNever include patient identifiers.

Workspace mode

Structured worksheet

Active local worksheet: mapped inputs can be completed, validated, copied, saved, and exported on this device. No numerical score is asserted unless its formula is independently reproducible.

On this pageWorksheet Clinical context References Discussion

Privacy by default

Inputs, results, favorites, and notes remain in your browser unless you explicitly export them.

Privacy details
Report formula or content issue
Continue exploring

Related clinical tools

More in this specialty
Interactive worksheet

UKPDS Coronary risk Calculator

General Cardiovascular Risk Assessment Scores
Interactive worksheet

Framingham Risk Score Calculator

General Cardiovascular Risk Assessment Scores
Interactive worksheet

QRISK3 Cardiovascular Risk Calculator

General Cardiovascular Risk Assessment Scores
Interactive worksheet

SCORE2 (European Society of Cardiology 2021) Calculator

General Cardiovascular Risk Assessment Scores
Clinical structure and calculation context point directly to Source 1; additional primary references remain listed for auditability.